259 related articles for article (PubMed ID: 27119750)
1. Novel targeted therapies in adrenocortical carcinoma.
Konda B; Kirschner LS
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):233-41. PubMed ID: 27119750
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers and targeted therapies for adrenocortical carcinoma.
Xu Y; Qi Y; Zhu Y; Ning G; Huang Y
Clin Endocrinol (Oxf); 2014 Feb; 80(2):159-68. PubMed ID: 24304415
[TBL] [Abstract][Full Text] [Related]
3. The next generation of therapies for adrenocortical cancers.
Kirschner LS
Trends Endocrinol Metab; 2012 Jul; 23(7):343-50. PubMed ID: 22626690
[TBL] [Abstract][Full Text] [Related]
4. New insights and future perspectives in the therapeutic strategy of adrenocortical carcinoma (Review).
Stigliano A; Cerquetti L; Lardo P; Petrangeli E; Toscano V
Oncol Rep; 2017 Mar; 37(3):1301-1311. PubMed ID: 28184938
[TBL] [Abstract][Full Text] [Related]
5. New targeted therapies for adrenocortical carcinomas.
Manso J; Pezzani R
Minerva Endocrinol; 2019 Mar; 44(1):70-81. PubMed ID: 29808641
[TBL] [Abstract][Full Text] [Related]
6. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S
Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844
[TBL] [Abstract][Full Text] [Related]
7. 5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications.
Lalli E; Sasano H
Horm Cancer; 2016 Feb; 7(1):44-8. PubMed ID: 26666256
[TBL] [Abstract][Full Text] [Related]
8. Current Prospects for Adrenocortical Carcinoma Pharmacotherapy.
Ławnicka H
Recent Pat Anticancer Drug Discov; 2023; 18(1):29-37. PubMed ID: 36482727
[TBL] [Abstract][Full Text] [Related]
9. 5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma.
Hoff AO; Berruti A
Horm Cancer; 2016 Feb; 7(1):29-35. PubMed ID: 26728470
[TBL] [Abstract][Full Text] [Related]
10. Medical management of adrenocortical carcinoma: Current recommendations, new therapeutic options and future perspectives.
Amodru V; Garcia ME; Libe R; Brue T; Reznik Y; Castinetti F
Ann Endocrinol (Paris); 2021 Feb; 82(1):52-58. PubMed ID: 33279475
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical carcinoma: the management of metastatic disease.
Fay AP; Elfiky A; Teló GH; McKay RR; Kaymakcalan M; Nguyen PL; Vaidya A; Ruan DT; Bellmunt J; Choueiri TK
Crit Rev Oncol Hematol; 2014 Nov; 92(2):123-32. PubMed ID: 24958272
[TBL] [Abstract][Full Text] [Related]
12. Management of Adrenocortical Carcinoma.
Jasim S; Habra MA
Curr Oncol Rep; 2019 Feb; 21(3):20. PubMed ID: 30798468
[TBL] [Abstract][Full Text] [Related]
13. Conventional chemotherapy and emerging targeted therapy for advanced adrenocortical carcinoma.
Xu YZ; Zhu Y
Anticancer Agents Med Chem; 2013 Feb; 13(2):248-53. PubMed ID: 22934700
[TBL] [Abstract][Full Text] [Related]
14. The challenge of developmental therapeutics for adrenocortical carcinoma.
Costa R; Carneiro BA; Tavora F; Pai SG; Kaplan JB; Chae YK; Chandra S; Kopp PA; Giles FJ
Oncotarget; 2016 Jul; 7(29):46734-46749. PubMed ID: 27102148
[TBL] [Abstract][Full Text] [Related]
15. Update in adrenocortical carcinoma.
Fassnacht M; Kroiss M; Allolio B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
[TBL] [Abstract][Full Text] [Related]
16. Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma.
Tai Y; Shang J
Front Endocrinol (Lausanne); 2023; 14():1260701. PubMed ID: 38269250
[TBL] [Abstract][Full Text] [Related]
17. Emerging drugs for the treatment of adrenocortical carcinoma.
Sukrithan V; Husain M; Kirschner L; Shah MH; Konda B
Expert Opin Emerg Drugs; 2021 Jun; 26(2):165-178. PubMed ID: 33896321
[No Abstract] [Full Text] [Related]
18. Advanced Adrenocortical Carcinoma: Current Perspectives on Medical Treatment.
Araújo AN; Bugalho MJ
Horm Metab Res; 2021 May; 53(5):285-292. PubMed ID: 33962475
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical Carcinoma: A Clinician's Perspective.
Elfiky A
Surg Pathol Clin; 2015 Dec; 8(4):751-4. PubMed ID: 26612225
[TBL] [Abstract][Full Text] [Related]
20. Adropin Stimulates Proliferation and Inhibits Adrenocortical Steroidogenesis in the Human Adrenal Carcinoma (HAC15) Cell Line.
Stelcer E; Milecka P; Komarowska H; Jopek K; Tyczewska M; Szyszka M; Lesniczak M; Suchorska W; Bekova K; Szczepaniak B; Ruchala M; Karczewski M; Wierzbicki T; Szaflarski W; Malendowicz LK; Rucinski M
Front Endocrinol (Lausanne); 2020; 11():561370. PubMed ID: 33133015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]